ストックスクリーナーアプリを入手
3.41
1.73%
-0.06
プレマーケット:
3.42
0.010
+0.29%
前日終値:
$3.47
開ける：
$3.4
24時間の取引高:
251.28K
Relative Volume:
0.19
時価総額：
$19.51M
収益：
-
当期純損益:
$-16.60M
株価収益率:
-3.8315
EPS:
-0.89
ネットキャッシュフロー:
$-23.48M
1週間 パフォーマンス:
+9.29%
1か月 パフォーマンス:
-14.75%
6か月 パフォーマンス:
-80.40%
1年 パフォーマンス:
-85.14%
1日の値動き範囲:
$3.29
$3.5499
1週間の範囲:
$3.00
$3.69
52週間の値動き範囲:
$2.814
$29.40
Briacell Therapeutics Corp Stock (BCTX) Company Profile
名前
Briacell Therapeutics Corp
セクター
電話
(604) 921-1810
住所
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER
BCTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BCTX
Briacell Therapeutics Corp
|
3.41 | 21.14M | 0 | -16.60M | -23.48M | -0.89 |
|
ONC
Beone Medicines Ltd Adr
|
251.72 | 25.78B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
446.48 | 114.53B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.3401 | 40.54M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
84.81 | 6.44B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
487.86 | 65.13B | 14.09B | 4.50B | 2.96B | 39.28 |
Briacell Therapeutics Corp Stock (BCTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-02-14 | 開始されました | H.C. Wainwright | Buy |
Briacell Therapeutics Corp (BCTX) 最新ニュース
BriaCell Announces Virtual Investor Presentations on Thursday, June 12 and Thursday, June 26 | BCTX Stock News - GuruFocus
BriaCell Announces Virtual Investor Presentations on Thursday, June 12 and Thursday, June 26 - GlobeNewswire
BriaCell’s Bria-IMT Shows Strong Survival & Benefit in Advanced Breast Cancer - Insider Monkey
Stocks In Play: BriaCell Therapeutics Corp. By Baystreet.ca - Investing.com Canada
BriaCell Therapeutics Corp. - Baystreet.ca
Stocks in play: BriaCell Therapeutics Corp. - The Globe and Mail
BriaCell Reports Promising Survival Data in Metastatic Breast Cancer Studies - TipRanks
BriaCell (BCTX) Shares Clinical Advancements at ASCO Meeting | B - GuruFocus
BriaCell Reports Robust Overall Survival and Clinical Benefit Data at ASCO 2025 - GlobeNewswire
Clinical Trial Success: BriaCell's Breast Cancer Treatment Outperforms FDA-Approved Therapies at ASCO 2025 - Stock Titan
(BCT) Stock Market Analysis (BCT:CA) - news.stocktradersdaily.com
(BCT) Market Dynamics and Trading Signals (BCT:CA) - news.stocktradersdaily.com
BriaCell Therapeutics (NASDAQ:BCTX) Stock Price Up 1.6% – Should You Buy? - Defense World
When (BCT) Moves Investors should Listen (BCT:CA) - news.stocktradersdaily.com
BriaCell Therapeutics Corp - Baystreet.ca
Cardiol Therapeutics Inc. - Baystreet.ca
BriaCell advances cancer treatment with Bria-OTS in clinical study By Investing.com - Investing.com South Africa
BriaCell Bria-OTS? Phase 1/2 Study Clears Safety Evaluation; Doses First Patient in Combination with Checkpoint Inhibitor - marketscreener.com
BriaCell advances cancer treatment with Bria-OTS in clinical study - Investing.com
BriaCell Advances Bria-OTS in Cancer Immunotherapy with New Study Phase - TipRanks
BriaCell (BCTX): Advances in Cancer Treatment with Bria-OTS | BC - GuruFocus
BriaCell Bria-OTS™ Phase 1/2 Study Clears Safety Evaluation; Dos - GuruFocus
BriaCell (BCTX): Advances in Cancer Treatment with Bria-OTS | BCTX Stock News - GuruFocus
BriaCell Bria-OTS™ Phase 1/2 Study Clears Safety - GlobeNewswire
BriaCell's Breast Cancer Immunotherapy Shows Early Success: Patient's Lung Metastasis Completely Resolved - Stock Titan
(BCT) Advanced Equity Analysis (BCT:CA) - news.stocktradersdaily.com
BriaCell Therapeutics: Stocks Undervalued by Analyst Consensus on TSX (BCT) - The Globe and Mail
BriaCell (BCTX) Showcases Promising Data at ASCO 2025 | BCTX Sto - GuruFocus
BriaCell Therapeutics Reports Promising Phase 2 Results for Metastatic Breast Cancer Treatment - TipRanks
BriaCell to Showcase Survival and Clinical Benefit Data at ASCO Meeting Next Week - marketscreener.com
BriaCell (BCTX) Showcases Promising Data at ASCO 2025 | BCTX Stock News - GuruFocus
BriaCell Abstracts Showcase Positive Survival and Clinical Benefit Data at ASCO 2025 - The Manila Times
‘Don’t Doubt UNH Yet,’ Top JPMorgan Analyst Defends UnitedHealth Stock amid Recent Volatility - The Globe and Mail
Breakthrough: BriaCell's New Breast Cancer Drug Shows 13.4-Month Survival Rate, Beating Standard Therapies - Stock Titan
OpenAI CEO Sam Altman Admits Even They Are ‘a Little Bit Scared’ of What They’re Building—But That’s a Good Thing - The Globe and Mail
Stock Market News Today, 5/22/25 – Futures Flat, Post Deficit-Fear-Driven Sell-Off - The Globe and Mail
Moderna Stock Looks Ripe for a Short Squeeze - The Globe and Mail
(BCT) Trading Signals (BCT:CA) - news.stocktradersdaily.com
BriaCell CEO Letter to Shareholders | BCTX Stock News - GuruFocus
BriaCell (BCTX) Reports Promising Advances in Cancer Treatment Studies | BCTX Stock News - GuruFocus
BriaCell Therapeutics Advances in Cancer Immunotherapy with Promising Clinical Results - TipRanks
Briacell Therapeutics CorpBria-Imt Receives FDA Fast Track Designation For Phase 3 Study - marketscreener.com
BriaCell CEO Letter to Shareholders - GlobeNewswire
Clinical Trial Breakthrough: BriaCell's Breast Cancer Therapy Shows 83% Success Rate, Surpassing Current Standard - Stock Titan
Public market insider buying at CGI (GIB) - The Globe and Mail
BriaCell Therapeutics (OTCMKTS:BCTXF) Stock Price Up 0.7% – Here’s Why - Defense World
Cisco Systems: A Safe Investment or a Stagnant Giant? - The Globe and Mail
(BCT) On The My Stocks Page (BCT:CA) - news.stocktradersdaily.com
BriaCell Therapeutics (CVE:BCT) Shares Down 3.8% – Here’s Why - Defense World
(BCT) Comprehensive Trading Strategy Report (BCT:CA) - news.stocktradersdaily.com
WonderFi Jumps Over 35% on Robinhood Acquisition News - The Globe and Mail
Briacell Therapeutics Corp (BCTX) 財務データ
収益
当期純利益
現金流量
EPS
0.87%
0.19%
大文字化:
|
ボリューム (24 時間):